FDA Inspection 1017980 — Gulf Coast Regional Blood Center

Gulf Coast Regional Blood Center — FEI 3005096242

The FDA completed an inspection of Gulf Coast Regional Blood Center on June 30, 2017 in Lufkin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 30, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lufkin, TX (United States)